2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$1.27-$0.06 (-4.36%)
Price as of Oct 22, 2026 7:57 PM EDT- $459.5MMarket Cap
- 9.92%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$1.27-$0.06 (-4.36%)
ALLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.33 | ||
Change | $0.00 (0.00%) | ||
Open | $1.33 | ||
High | $1.36 | ||
Low | $1.31 | ||
Previous Close | $1.33 | ||
Volume | 4,742,435 | ||
30-Day Average Volume | 5,660,904 | ||
1-Week Change | 2.31% | ||
1-Month Change | -21.30% | ||
1-Year Change | 9.92% | ||
3-Year Change | -55.67% | ||
5-Year Change | -91.66% | ||
Fundamentals | |||
Shares Outstanding | 345.5M | ||
Total Assets | $550.1M | ||
Market Cap | $459.5M | ||
Enterprise Value | $420.9M | ||
Period: QTR TTM FY | |||
Revenue | $4.6M | ||
Net Income | -$42.7M | ||
Free Cash Flow | -$32.1M | ||
EBIT | -$42.7M | ||
EBITDA | -$40.0M | ||
Net Working Capital | $308.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 91 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue